This document establishes the updated financial requirements for licensing under the Misuse of Drugs Act 1971. The text is issued by the British government to formalize the specific fee adjustments for entities or individuals seeking authorization to handle controlled substances. It serves as a regulatory instrument to ensure compliance with administrative costs associated with drug oversight.

Legal professionals and government archivists utilize this text as a primary source for tracking the evolution of administrative costs in British drug policy. It is considered a technical reference document for those researching the regulatory history of controlled substance management in the United Kingdom.